AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

/
AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

DANNCE.AI is bringing to market a novel phenotyping platform to digitize the clinical assessments used by clinicians and drug developers to quantify movement. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

Read More

Reimagining the Relationship Between Humans & Machines with Neural Interface Technology

/
Reimagining the Relationship Between Humans & Machines with Neural Interface Technology

In 2019, we had the pleasure of hosting a fireside chat between Thomas Reardon, a computational neuroscientist, co-founder and CEO of CTRL-labs, and Evan Nisselson, Founder and General Partner at LDV Capital.

Four months later in September 2019, CTRL-Labs was acquired by Facebook for approximately $1 billion, reported VentureBeat. He and his team are now integrated into Facebook's AR/VR research group.

Read More